In the near-patient clinical lab, acute conditions like respiratory disease require immediate intervention. Correct identification of the causative pathogen is key to selecting the right treatment, but many respiratory pathogens cause similar symptoms. This makes it difficult for scientists to know which one they’re up against.
Multiplex syndromic testing rapidly and simultaneously surveys a large number of pathogens, giving users the answers they need when they need them.
Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time. The TGA registered panels are available now in Australia.
For more information: https://qiastat-dx.com/row/are-you-ready-for-a-new-era-in-multiplex-syndromic-testing/.
Phone: 03 9840 9800
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Grace Bio-Labs protein microarray tools
Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...
Siemens Healthineers 3gAllergy assay
Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...
Learn More
I am interested in QIAGEN QIAstat-Dx syndromic testing instrument.
Complete the form and a supplier representative will be in touch.
